abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb

このページは 日本語 では利用できません。English で表示されています

記事

2005年2月1日

著者:
Doctors Without Borders/Médecins Sans Frontières

Data Exclusivity & Access to Medicines in Guatemala

...generic competition [in Guatemala and elsewhere] has been effective in bringing down prices...[and] making life-extending treatment available...this access is now being threatened...[by “free trade agreements” with the USA] that limit generic competition and the ability of countries...to protect public health and ensure access to medicines...Treating fewer people means condemning others to premature death. [refers to GlaxoSmithKline, Bristol-Myers Squibb]